Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma

Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways

(2012) Cédric Coulouarn et al.   CARCINOGENESIS

Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction?

(2012) Ching-Sheng Hsu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI

(2012) Jiyoung Hwang et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Combined hepatocellular carcinoma-cholangiocarcinoma: Report of MR appearance in eleven patients

(2012) Rafael O.P. de Campos et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma

(2012) Mitsumaro Itoyama et al.   Medical Molecular Morphology

Magnetic resonance imaging of focal liver lesions: Approach to imaging diagnosis

(2011) Kathryn J. Fowler et al.   HEPATOLOGY

Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma

(2011) Gonzalo Sapisochin et al.   LIVER TRANSPLANTATION

The Diagnostic Conundrum and Liver Transplantation Outcome for Combined Hepatocellular-Cholangiocarcinoma

(2010) C. Panjala et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of combined hepatocellular and cholangiocarcinoma

(2008) W. T. Kassahun et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE